Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 14, Issue 19
|
pp. 7866–7876
Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma
Back to article
Figure 3
(3 of 9)
−
100%
+
Figure 3.
Clinical significance of DTYMK in lung adenocarcinoma.
Correlation between DTYMK expression and clinical parameters, including (
A
) pathological stage, (
B
–
D
) TNM stage NS: P >0.05, ***P < 0.001.